Are expensive vaccines the best investment in low-income and middle-income countries?

Lone Simonsen, Maarten van Wijhe, Robert Taylor
2019 Lancet Global Health  
doi:10.1016/s2214-109x(19)30040-3 pmid:31000121 fatcat:kono6accyvdc3fgm4lwo4oawhe